SCOPUS 정보 검색 플랫폼

Journal of the American Academy of Dermatology

Volumn 66, Issue 6, 2012, Pages

A case of rapid improvement of severe psoriasis during molecular-targeted therapy using an epidermal growth factor receptor tyrosine kinase inhibitor for metastatic lung adenocarcinoma

(4) Oyama, Noritaka a,b Kaneko, Fumio b Togashi, Ari b Yamamoto, Toshiyuki a

a FUKUSHIMA MEDICAL UNIVERSITY (Japan)

b Southern Tohoku General Hospital and Southern Tohoku Research Institute for Neuroscience (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; ANTIHISTAMINIC AGENT; DIFLUPREDNATE; ERLOTINIB;

ADULT; ANAMNESIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; LETTER; LUNG ADENOCARCINOMA; MALE; METASTASIS; MOLECULARLY TARGETED THERAPY; MONOTHERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSORIASIS; TRANSBRONCHIAL BIOPSY;

EID: 84862103871 PISSN: 01909622 EISSN: 10976787 Source Type: Journal
DOI: 10.1016/j.jaad.2011.08.009 Document Type: Article

Times cited : (10)

References (6)

1
- 33748935930
- Dermatologic side effects associated with the epidermal growth factor receptor inhibitors
- A.L. Agero, S.W. Dusza, C. Benvenuto-Andrade, K.J. Busam, P. Myskowski, and A.C. Halpern Dermatologic side effects associated with the epidermal growth factor receptor inhibitors J Am Acad Dermatol 55 2006 657 670
- (2006) J Am Acad Dermatol , vol.55 , pp. 657-670
- Agero, A.L.¹ Dusza, S.W.² Benvenuto-Andrade, C.³ Busam, K.J.⁴ Myskowski, P.⁵ Halpern, A.C.⁶

2
- 33745020186
- Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma: A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?
- E. Wierzbicka, J.M. Tourani, and G. Guillet Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma: a role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis? Br J Dermatol 155 2006 213 214
- (2006) Br J Dermatol , vol.155 , pp. 213-214
- Wierzbicka, E.¹ Tourani, J.M.² Guillet, G.³

3
- 77950408289
- Improvement of psoriasis in a lung cancer patient treated with erlotinib
- E. Giroux Leprieur, S. Friard, and L.J. Couderc Improvement of psoriasis in a lung cancer patient treated with erlotinib Eur J Dermatol 20 2010 243 244
- (2010) Eur J Dermatol , vol.20 , pp. 243-244
- Giroux Leprieur, E.¹ Friard, S.² Couderc, L.J.³

4
- 13244284850
- The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin
- C. Johansen, K. Kragballe, M. Westergaard, J. Henningsen, K. Kristiansen, and L. Iversen The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin Br J Dermatol 152 2005 37 42
- (2005) Br J Dermatol , vol.152 , pp. 37-42
- Johansen, C.¹ Kragballe, K.² Westergaard, M.³ Henningsen, J.⁴ Kristiansen, K.⁵ Iversen, L.⁶

5
- 3242711418
- Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor
- M.P. Zorzou, A. Stratigos, E. Efstathiou, and A. Bamias Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor Acta Derm Venereol 84 2004 308 309
- (2004) Acta Derm Venereol , vol.84 , pp. 308-309
- Zorzou, M.P.¹ Stratigos, A.² Efstathiou, E.³ Bamias, A.⁴

6
- 0038306878
- Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation
- F. Mascia, V. Mariani, G. Girolomoni, and S. Pastore Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation Am J Pathol 163 2003 303 312
- (2003) Am J Pathol , vol.163 , pp. 303-312
- Mascia, F.¹ Mariani, V.² Girolomoni, G.³ Pastore, S.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.